These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15636469)

  • 1. Evaluation of proposals of Belgian Social Security Institute for reimbursement of bone densitometry tests. Toward a cost-effective strategy for osteoporosis screening?
    Ben Sedrine W; Ethgen O; Devogelaer JP; Depresseux G; Kaufman JM; Goemaere S; Reginster JY
    Aging Clin Exp Res; 2004 Oct; 16(5):413-9. PubMed ID: 15636469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interest of a prescreening questionnaire to reduce the cost of bone densitometry.
    Ben Sedrine W; Broers P; Devogelaer JP; Depresseux G; Kaufman JM; Goemaere S; Reginster JY
    Osteoporos Int; 2002 May; 13(5):434-42. PubMed ID: 12086356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for osteoporosis using easily obtainable biometrical data: diagnostic accuracy of measured, self-reported and recalled BMI, and related costs of bone mineral density measurements.
    van der Voort DJ; Brandon S; Dinant GJ; van Wersch JW
    Osteoporos Int; 2000; 11(3):233-9. PubMed ID: 10824239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention of osteoporosis: mass screening scenario or prescreening with questionnaires? An economic perspective.
    Richy F; Ethgen O; Bruyere O; Mawet A; Reginster JY
    J Bone Miner Res; 2004 Dec; 19(12):1955-60. PubMed ID: 15537437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density referral for dual-energy X-ray absorptiometry using quantitative ultrasound as a prescreening tool in postmenopausal women from the general population: a cost-effectiveness analysis.
    Marín F; López-Bastida J; Díez-Pérez A; Sacristán JA;
    Calcif Tissue Int; 2004 Mar; 74(3):277-83. PubMed ID: 14708042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in a sample of white women from Belgium.
    Ben Sedrine W; Devogelaer JP; Kaufman JM; Goemaere S; Depresseux G; Zegels B; Deroisy R; Reginster JY
    Bone; 2001 Oct; 29(4):374-80. PubMed ID: 11595621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis case finding in the general practice: phalangeal radiographic absorptiometry with and without risk factors for osteoporosis to select postmenopausal women eligible for lumbar spine and hip densitometry.
    Gasser KM; Mueller C; Zwahlen M; Kaufmann M; Fuchs G; Perrelet R; Abetel G; Bürgi U; Lippuner K
    Osteoporos Int; 2005 Nov; 16(11):1353-62. PubMed ID: 15711776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for osteopenia and osteoporosis: selection by body composition.
    Michaëlsson K; Bergström R; Mallmin H; Holmberg L; Wolk A; Ljunghall S
    Osteoporos Int; 1996; 6(2):120-6. PubMed ID: 8704349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Yoshimura M; Moriwaki K; Noto S; Takiguchi T
    Osteoporos Int; 2017 Feb; 28(2):643-652. PubMed ID: 27743068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of accuracy and cost effectiveness of clinical criteria and BUA for referral for BMD assessment by DXA in osteoporotic and osteopenic perimenopausal subjects.
    Langton CM; Langton DK; Beardsworth SA
    Technol Health Care; 1999; 7(5):319-30. PubMed ID: 10543417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis.
    Kingkaew P; Maleewong U; Ngarmukos C; Teerawattananon Y
    Value Health; 2012; 15(1 Suppl):S20-8. PubMed ID: 22265062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of the osteoporosis prescreening risk assessment (OPERA) tool to facilitate identification of women likely to have low bone density.
    Salaffi F; Silveri F; Stancati A; Grassi W
    Clin Rheumatol; 2005 Jun; 24(3):203-11. PubMed ID: 15549501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland.
    Schwenkglenks M; Lippuner K
    Osteoporos Int; 2007 Nov; 18(11):1481-91. PubMed ID: 17530156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of women at increased risk of osteoporosis: no need to use different screening tools at different ages.
    Dargent-Molina P; Piault S; Bréart G
    Maturitas; 2006 Apr; 54(1):55-64. PubMed ID: 16202546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FRAX without bone mineral density versus osteoporosis self-assessment screening tool as predictors of osteoporosis in primary screening of individuals aged 70 and older.
    Pang WY; Inderjeeth CA
    J Am Geriatr Soc; 2014 Mar; 62(3):442-6. PubMed ID: 24617899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women.
    Mueller D; Gandjour A
    Value Health; 2009; 12(8):1106-17. PubMed ID: 19706151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic evaluation of osteoporosis screening strategy conducted in the Province of Liège with the cooperation of Liège Province Santé].
    Hiligsmann M; Bruyère O; Pire G; Reginster JY
    Rev Med Liege; 2008 Oct; 63(10):588-94. PubMed ID: 19009966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.
    Schousboe JT; Ensrud KE; Nyman JA; Melton LJ; Kane RL
    J Am Geriatr Soc; 2005 Oct; 53(10):1697-704. PubMed ID: 16181168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness analysis of using quantitative ultrasound as a selective pre-screen for bone densitometry.
    Sim MF; Stone MD; Phillips CJ; Cheung WY; Johansen A; Vasishta S; Pettit RJ; Evans WD
    Technol Health Care; 2005; 13(2):75-85. PubMed ID: 15912005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.
    Ito K; Leslie WD
    Osteoporos Int; 2015 Aug; 26(8):2111-9. PubMed ID: 25807913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.